| Authors: |
Lot Aronson S; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands., van Stein RM; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands., Algera MD; Scientific Bureau, Dutch Institute for Clinical Auditing (DICA), Leiden, The Netherlands; Maastricht University Medical Center, Department of Obstetrics and Gynecology, Maastricht, The Netherlands; GROW- School for Oncology and Reproduction, Maastricht, The Netherlands., Lopez-Yurda M; The Netherlands Cancer Institute, Department of Biometrics, Amsterdam, The Netherlands., van der Aa MA; Netherlands Comprehensive Cancer Organization (IKNL), Department of Research & Development, Utrecht, The Netherlands., Lok CAR; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Sonke GS; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands., van Driel WJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands. Electronic address: w.v.driel@nki.nl. |
